SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Updated Phase 2 lung-cancer data for lifileucel24.6% overall response and 59.1% in a small biomarker-enriched subgroupsparked a sharp selloff and debate over whether the subgroup findings narrow the addressable market and complicate the regulatory path. Some traders view the overall results and enriched response signal as encouraging, while others are concerned about validation, response-duration details, and the planned 2027 filing timeline.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Alphabets quarterly results sparked a sharp selloff, with traders focused on heavy AI infrastructure spending and negative free cash flow alongside slowing Search and advertising growth. The debate centers on whether strong Cloud and Gemini momentum can justify the investment: some see an overreaction and buying opportunity, while others question AI monetization and future returns.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsofts fiscal first-quarter results beat expectations, with Azure growth accelerating to 48% and its outlook pointing to further growth; traders welcomed the cloud performance but debated whether heavy AI investment, lower-than-expected reported capex amid capacity delays, and a new bond offering could limit the upside. The initial post-earnings rally faded, with some attributing the pullback to broader weakness in tech and Alphabets results.

Alphabet Inc - Ordinary Shares - Class C

Alphabets earnings miss has put the shares under pressure, with traders focused on slowing Search and advertising momentum and heavy AI investment raising concerns about cash flow and returns. Some view the selloff as overdone given strong Cloud growth, while bears question whether AI competition and rising spending will erode profitability.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracles investor-day outlookmapping a path to positive free cash flow, limiting additional financing, and forecasting strong long-term growthhelped ease concerns about the cost of its AI data-center expansion and drove a sharp rally. Traders welcomed the greater financial clarity, while skeptics questioned whether management can deliver and warned that debt, execution risks, and weakness elsewhere in tech could pressure the shares.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNows quarterly earnings miss and softer outlook for contracted-revenue growth triggered a sharp selloff, overshadowing revenue growth and raised AI targets. Traders are split between calling the reaction an overreaction and seeing it as a warning about slowing growth, elevated expectations, and AI-related risks to enterprise software.

Norwegian Cruise Line Holdings Ltd. engages in the provision of cruise travel services. It offers cruise experiences for travelers with itineraries in Europe, Asia, Australia, New Zealand, South America, Africa, Canada, Bermuda, Caribbean, Alaska and Hawaii. Its brands include Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises. The company was founded in 1966 and is headquartered in Miami, FL.

Norwegian Cruise Line Holdings Ltd

Norwegians quarterly results beat expectations and the company raised its full-year outlook, driving a relief rally after prolonged weakness and analyst downgrades. Traders are celebrating the results and speculating about short covering, while others remain cautious about yields, debt, fuel costs, and whether management can sustain the improvement.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Reports that Marvell is in advanced talks to acquire Lumentum have driven discussion, though no deal is final. Traders debate the strategic value of adding scarce optical components for AI data centers against financing, dilution and integration risks; some see long-term benefits while others view the potential deal as a near-term negative.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Lillys strong third-quarter results and higher full-year revenue outlook, driven by demand for Mounjaro and Zepbound, are drawing bullish attention and fueling discussion of continued GLP-1 growth. Some traders caution that profit guidance was trimmed amid deal-related charges, Foundayos launch is facing questions, and valuation is demanding; retatrutides trial results add to the pipeline optimism.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLASs Phase 3 REGAL AML trial reached its prespecified 80th event, triggering final analysis ahead of preliminary topline results expected this quarter; the update did not disclose whether GPS improved survival. The milestone was followed by a sharp selloff, with traders debating whether it was a shakeout or profit-taking while others stressed the binary risk ahead of the data.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


tipclub14org

Tipclub